TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,804 | -62.3% | 26,412 | +11.9% | 0.00% | -66.7% |
| Q2 2023 | $586,398 | +74.4% | 23,607 | +5.6% | 0.00% | +50.0% |
| Q1 2023 | $336,234 | +27.1% | 22,356 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $264,471 | +147.2% | 22,356 | +23.8% | 0.00% | 0.0% |
| Q3 2022 | $107,000 | +39.0% | 18,059 | 0.0% | 0.00% | – |
| Q2 2022 | $77,000 | -55.2% | 18,059 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $172,000 | -40.7% | 18,059 | +18.3% | 0.00% | 0.0% |
| Q4 2021 | $290,000 | -20.5% | 15,264 | +39.0% | 0.00% | -50.0% |
| Q3 2021 | $365,000 | -14.3% | 10,978 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $426,000 | -19.5% | 10,978 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $529,000 | -16.4% | 10,978 | -9.8% | 0.00% | -25.0% |
| Q4 2020 | $633,000 | +110.3% | 12,164 | +8.2% | 0.00% | +100.0% |
| Q3 2020 | $301,000 | +95.5% | 11,238 | +41.7% | 0.00% | +100.0% |
| Q2 2020 | $154,000 | +161.0% | 7,929 | +31.4% | 0.00% | 0.0% |
| Q1 2020 | $59,000 | +20.4% | 6,032 | +37.5% | 0.00% | – |
| Q4 2019 | $49,000 | +96.0% | 4,387 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -34.2% | 4,387 | 0.0% | 0.00% | – |
| Q2 2019 | $38,000 | +8.6% | 4,387 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | +94.4% | 4,387 | 0.0% | 0.00% | – |
| Q4 2018 | $18,000 | -28.0% | 4,387 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | -56.9% | 4,387 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $58,000 | -6.5% | 4,387 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $62,000 | +244.4% | 4,387 | +94.5% | 0.00% | – |
| Q4 2017 | $18,000 | -33.3% | 2,255 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | +17.4% | 2,255 | 0.0% | 0.00% | – |
| Q2 2017 | $23,000 | -11.5% | 2,255 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +160.0% | 2,255 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | -41.2% | 2,255 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | +21.4% | 2,255 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | -26.3% | 2,255 | 0.0% | 0.00% | – |
| Q1 2016 | $19,000 | -29.6% | 2,255 | 0.0% | 0.00% | – |
| Q4 2015 | $27,000 | +350.0% | 2,255 | +307.8% | 0.00% | – |
| Q3 2015 | $6,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |